The prognostic utility of baseline pre-treatment blood levels of mucin-1 in patients with idiopathic pulmonary fibrosis (IPF) receiving antifibrotics has not yet been fully established. This evidence concerns the gene MUC1 and idiopathic pulmonary fibrosis.